Pancreatic Cancer Research

ResearcherGifu University HospitalActive in the last 2 years

Nobuhisa Matsuhashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5993-9571; OpenAlex author ID A5061553422, A5110221060. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: 1 paper

Papers 10

  1. Urine-based nematode chemotaxis assay (N-NOSE) as a predictor of recurrence after curative surgery for resectable pancreatic cancer: preliminary data and singl… Last author DOI 10.1186/s12893-025-03355-0↗
  2. Clinical impact of intraoperative pancreatic transection margin analysis and additional resection during pancreaticoduodenectomy for pancreatic ductal adenocar… Last author DOI 10.1016/j.pan.2024.10.003↗
  3. Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer. Co-author DOI 10.1038/s41416-024-02834-0↗
  4. Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery. Co-author DOI 10.3390/cancers16122271↗
  5. Pretherapeutic factors predicting conversion surgery in unresectable pancreatic ductal adenocarcinoma: A retrospective study. Last author DOI 10.3892/ol.2024.14304↗
  6. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer. Co-author DOI 10.1038/s41416-023-02189-y↗
  7. Early Predictive Factors for Postoperative Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Cancer. Co-author DOI 10.21873/cdp.10128↗
  8. Splenic artery transposition for hepatic arterial reconstruction in conversion surgery of an initially unresectable, locally advanced pancreatic cancer after g… Co-author DOI 10.1016/j.ijscr.2020.12.041↗
  9. Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report. Co-author DOI 10.1016/j.ijscr.2021.105715↗
  10. Significance of Preoperative Pancreatic MRI Findings in Predicting Factors for Postoperative Pancreatic Fistula after Distal Pancreatectomy for Pancreatic Canc… Co-author DOI 10.21203/rs.3.rs-641857/v1↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Fukada · 5 shared papers, 2021–2025 · strength 0.86
  2. Toshiya Higashi · 5 shared papers, 2021–2024 · strength 0.79
  3. Kazuhiro Yoshida · 3 shared papers, 2021–2024 · strength 0.45
  4. Hideharu Tanaka · 3 shared papers, 2021 · strength 0.44
  5. Kazuhiro Yoshida · 2 shared papers, 2021–2022 · strength 0.32
  6. Kentaro Sudo · 2 shared papers, 2023–2024 · strength 0.28
  7. Kumiko Umemoto · 2 shared papers, 2023–2024 · strength 0.28
  8. Nobumasa Mizuno · 2 shared papers, 2023–2024 · strength 0.28
  9. Masayuki Furukawa · 2 shared papers, 2023–2024 · strength 0.28
  10. Masafumi Ikeda · 2 shared papers, 2023–2024 · strength 0.28
  11. Naohiro Okano · 2 shared papers, 2023–2024 · strength 0.28
  12. Koushiro Ohtsubo · 2 shared papers, 2023–2024 · strength 0.28
  13. Yasuyuki Kawamoto · 2 shared papers, 2023–2024 · strength 0.28
  14. Shinji Itoh · 2 shared papers, 2023–2024 · strength 0.28
  15. Makoto Ueno · 2 shared papers, 2023–2024 · strength 0.28
  16. Chigusa Morizane · 2 shared papers, 2023–2024 · strength 0.28
  17. Eric di Luccio · 1 shared paper, 2025 · strength 0.22
  18. Seiji Natsume · 1 shared paper, 2024 · strength 0.20
  19. Kazuo Hara · 1 shared paper, 2024 · strength 0.20
  20. Waki Hosoda · 1 shared paper, 2024 · strength 0.20
  21. Tomonari Asano · 1 shared paper, 2024 · strength 0.20
  22. Kakeru Tawada · 1 shared paper, 2024 · strength 0.20
  23. Takuji Iwashita · 1 shared paper, 2024 · strength 0.18
  24. Masahito Shimizu · 1 shared paper, 2024 · strength 0.18
  25. Masayuki Matsuo · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.